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Cellular/Molecular
Cyclin-Dependent Kinase 5 Regulates PSD-95 Ubiquitination
in Neurons
Michael J. Bianchetta,1 TuKiet T. Lam,2 Stephen N. Jones,1 andMaria A. Morabito1
1Department of Cell Biology, University of Massachusetts Medical School, Worcester, Massachusetts 01655 and 2W. M. Keck Foundation Biotechnology
Resource Laboratory, Yale University, New Haven, Connecticut 06511
Cyclin-dependent kinase 5 (Cdk5) and its activator p35 have been implicated in drug addiction, neurodegenerative diseases such as
Alzheimer’s, learning andmemory, and synapsematurationandplasticity.However, themolecularmechanismsbywhichCdk5 regulates
synaptic plasticity are still unclear. PSD-95 is amajor postsynaptic scaffolding protein of glutamatergic synapses that regulates synaptic
strength andplasticity. PSD-95 is ubiquitinatedby theubiquitinE3 ligaseMdm2, and rapid and transient PSD-95ubiquitinationhasbeen
implicated in NMDA receptor-induced AMPA receptor endocytosis. Here we demonstrate that genetic or pharmacological reduction of
Cdk5activity increases the interactionofMdm2withPSD-95andenhancesPSD-95ubiquitinationwithout affectingPSD-95protein levels
in vivo inmice, suggesting anonproteolytic functionof ubiquitinatedPSD-95 at synapses.We show that PSD-95ubiquitination correlates
with increased interactionwith-adaptin, a subunit of the clathrinadaptorprotein complexAP-2.This interaction is increasedbygenetic
reduction of Cdk5 activity or NMDA receptor stimulation and is dependent onMdm2. Together these results support a function for Cdk5
in regulating PSD-95 ubiquitination and its interaction with AP-2 and suggest a mechanism by which PSD-95 may regulate NMDA
receptor-induced AMPA receptor endocytosis.
Introduction
Cyclin-dependent kinase 5 (Cdk5) is a proline-directed serine/
threonine kinase expressed in theCNS that, with its activator p35,
is implicated in synaptic plasticity, learning and memory, drug
addiction, andneurodegeneration (Angelo et al., 2006; Cheung et
al., 2006; Hawasli and Bibb, 2007; Lai and Ip, 2009). Cdk5 is
inactivated followingNMDA receptor stimulation or depolariza-
tion (Schuman and Murase, 2003; Wei et al., 2005), and Cdk5’s
role in synaptic plasticity is underscored by enhanced long-term
potentiation (LTP) in conditional Cdk5 knock-out mice (Ha-
wasli et al., 2007) and a lower threshold for LTP induction and
impaired long-term depression (LTD) in p35 knock-out mice
(Ohshima et al., 2005; Wei et al., 2005).
PSD-95 (SAP90) is amajor postsynaptic scaffolding protein of
glutamatergic synapses and a substrate of Cdk5 (Morabito et al.,
2004). PSD-95 has been implicated in synaptic maturation and
regulation of synaptic strength and plasticity (Kim and Sheng,
2004; Funke et al., 2005; Be´ïque et al., 2006; Elias and Nicoll,
2007). The importance of PSD-95 in synaptic plasticity is under-
scored by the inhibition of NMDA receptor (NMDAR)-induced
AMPA receptor (AMPAR) internalization and the impairment of
LTD following PSD-95 knockdown (Xu et al., 2008; Bhattacha-
ryya et al., 2009). The rapid and transient ubiquitination of
PSD-95 by the ubiquitin E3 ligase Mdm2 has been implicated in
NMDAR-induced endocytosis of AMPARs (Colledge et al.,
2003), but the mechanisms regulating this posttranslational
modification of PSD-95 are still unclear.
Since Cdk5 is inactivated by NMDAR stimulation (Wei et al.,
2005), we investigated whether inactivation of Cdk5 promotes
PSD-95 ubiquitination. In this study we report that PSD-95 is
ubiquitinated in neurons with reduced Cdk5 activity without
affecting PSD-95 protein levels in vivo.We also show that PSD-95
ubiquitination correlates with increased interaction of PSD-95
with -adaptin, a subunit of the clathrin adaptor protein com-
plex AP-2, and that this interaction is increased under reduced
Cdk5 activity or by NMDAR stimulation and is dependent on
Mdm2. Together these results suggest a nonproteolytic signaling
function for PSD-95 ubiquitination and support a novel function
for Cdk5 in the regulation of glutamatergic synapses.
Materials andMethods
Mice. Adult p35 knock-out mice and control littermates were gifts from
Dr. Li-Huei Tsai (Massachusetts Institute of Technology, Cambridge,
MA). Mdm2/p53 double knock-out mice, p53 knock-out mice, and p35
knock-outmice have been described previously (Donehower et al., 1992;
Jones et al., 1995; Chae et al., 1997). All mice were bred and analyzed in
accordance with institutional guidelines and as approved by the Institu-
tional Animal Care and Use Committee of the University of Massachu-
setts Medical School, Worcester, MA.
Acute forebrain slices.Acute forebrain slices were prepared as described
previously (Zhang et al., 2008). Briefly, brains of adult wild-type mice of
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either sex were isolated, and 300 m coronal slices of forebrain (within
the region corresponding approximately to1.0 to3.5mmfrombregma,
containing the hippocampus) were prepared using a Vibratome (VT1000S;
LeicaMicrosystems) in ice-cold oxygenated artificial CSF (ACSF) contain-
ing the following (in mM): 117 NaCl, 1.7 KCl, 1.2 MgCl2, 2.5 CaCl2, 1.2
NaH2PO4, 25 NaHCO3, and 11.5 glucose. Slices were preincubated in
ACSF for 1 h before treatments and all experiments were conducted at
32°C in 95% O2 and 5% CO2 incubator. Slice lysates were prepared as
described previously (Zhang et al., 2008), and PSD-95 immunoprecipi-
tated from the lysates was analyzed by Western blot and quantified as
described above. Values are expressed as mean SEM and were statisti-
cally compared using Student’s t test or a two-way ANOVA.
Western blots of brain lysates. Brain lysates were prepared according to
Zhang et al., (2008). Briefly, brains (without cerebellum) were first ho-
mogenized and lysed in 1% deoxycholate (DOC) lysis buffer (150 mM
NaCl, 50 mM Tris, pH 8.8, 1% DOC), to which an equal volume of
modified RIPAwas added (150mMNaCl, 50mMTris/HCl, pH 7.4, 1mM
EDTA, 1% Triton X-100, 0.1% SDS) (Kalia et al., 2006). All buffers were
supplemented with protease and phosphatase inhibitor cocktails
(Roche). Lysate protein concentrations were determined by Detergent
Compatible Protein Assay (Bio-Rad). Immunoprecipitations and West-
ern blot analysis were performed as described previously (Zhang et al.,
2008). Antibodies used were mouse monoclonals Mdm2 (Millipore),
PSD-95 (Antibodies Incorporated); ubiquitin (BD Transduction), FK1
(Biomol/Enzo Life Sciences), and FK2 (Biomol/Enzo Life Sciences).
Western blots were visualized by enhanced chemiluminescence (GE
Healthcare), and immunoreactive bands were digitally scanned and
quantified with ImageJ software (NIH). Coimmunoreactivity was nor-
malized to the level of immunoprecipitated PSD-95 and expressed as a
percentage of control levels. Values are expressed as mean  SEM and
were statistically compared using Student’s t test.
Mass spectrometry. PSD-95 was immunoprecipitated from acute
mouse forebrain slices treatedwith roscovitine as described above (Acute
forebrain slices). Each eluted protein sample was reduced and alkylated,
digested with either LysC/Trypsin or GluC/Trypsin, and phosphoen-
riched with an in-house developed TiO2 enrichment strategy (Rinehart
et al., 2009) to optimize for the observed 80% sequence coverage,
which encompasses 29 of the 38 lysines in mouse PSD-95. Both flow-
through and phosphoenriched fractions were injected onto a C18 RP
Atlantis column attached to a nanoACQUITY UPLC system in line with
a hybrid LTQ or Velos Orbitrap LC MS/MS instrument. Collected raw
data from 13 experiments were processed by Distiller software (Matrix
Science) and searched with the MASCOT search engine. Ubiquitinated
sites were identified by the addition of a Gly–Gly moiety on lysines and
were manually validated.
Dissociated hippocampal cultures and immunocytochemistry. Dissoci-
ated hippocampal cultures were prepared from E17–E18 rat brains as
described previously (Zhang et al., 2008). Hippocampal neurons were
plated on coverslips coated with poly-D-lysine and laminin at a density of
6600/cm2 and grown in Neurobasal medium supplemented with B27
andGlutaMax (Invitrogen) for 17–21 d in vitro. Cultures were treated for
45 min with 10 M roscovitine or DMSO as a control, fixed in 4% para-
formaldehyde, 5% sucrose in PBS for 15 min, and then permeabilized in
blocking buffer (10% BSA, 0.2% Triton X-100 in PBS) for 1 h. Cultures
were then stained using rabbit polyclonal PSD-95 antibody (Zymed) to-
gether with mouse monoclonal antibody Mdm2 (Millipore) or -adaptin
(BD Transduction Laboratories) and secondary antibodies (Alexa 488- and
Alexa 594-conjugated; Invitrogen), and mounted in Vectashield (Vector
Laboratories). Omission of primary antibody was used as the control for
specificity of staining. Each experimental treatment and analysis was
performed blind using raw images from three experiments and six cov-
erslips. Images were captured using a Leica TCS laser-scanning confocal
microscope under identical conditions (63 objective, 1024  1024
pixel format, and identical settings). Images from each experiment (n)
were thresholded using identical values and analyzed by MetaMorph
software. The number of costained puncta, as percentage of total PSD-95
puncta, was expressed as a percentage of the number for DMSO controls.
The colocalization was expressed as mean SEM and statistically com-
pared using Student’s t test.
Results
Decreased Cdk5 activity increases PSD-95 ubiquitination
To assess whether Cdk5 regulates PSD-95 ubiquitination, we an-
alyzed the levels of PSD-95 ubiquitination in p35 knock-out
mice, which have reduced Cdk5 activity by 78% (Hallows et al.,
2006). Immunoblotting of PSD-95 immunoprecipitated from
brain revealed a more than fourfold increase in PSD-95 ubiquiti-
nation in p35 knock-out mice compared to wild-type littermates
(431.3 84.4%vs 100 18.5% forwild type;n 3; p 0.05; Fig.
1A), with a pattern of discrete bands closely resembling those
observed by Colledge et al. (2003). We also determined the levels
of PSD-95 ubiquitination in acute mouse forebrain slices in
which Cdk5 was inhibited pharmacologically by treatment with
the Cdk5 inhibitor roscovitine (Fig. 1B). Consistent with the
increase in PSD-95 ubiquitination observed in p35 knock-out
mice, pharmacological inhibition of Cdk5 by roscovitine resulted
in a more than twofold increase in PSD-95 ubiquitination
(274.6 71.6% vs 100 54.5% for untreated control; n 4; p
0.01). Together, these data indicate that decreased Cdk5 activity
results in increased PSD-95 ubiquitination.
PSD-95 contains multiple protein–protein interaction motifs
including an N-terminal domain, three PDZ domains, an SH3
Figure 1. Reduced Cdk5 activity promotes PSD-95 ubiquitination. A, p35 knock-out mice have
increased PSD-95 ubiquitination. Immunoblots of PSD-95 immunoprecipitated frombrain lysates of
wild-type (/) and p35 knock-out (/) mice revealed discrete bands representing increased
PSD-95 ubiquitination in p35 knock-outmice. Quantification (mean SEM) revealed that ubiquiti-
nation of PSD-95 was 431.3 84.4% versus 100 18.5% for wild type (n 3; p 0.05). The
ubiquitin immunoreactivity was normalized to the level of immunoprecipitated PSD-95 and ex-
pressed as a percentage ofwild-type control.B, Roscovitine treatment increases PSD-95 ubiquitina-
tion.Acutemouse forebrainsliceswere treatedwith theCdk5 inhibitor roscovitine (10M,45min)or
DMSO as the control. Immunoblots of PSD-95 immunoprecipitated from lysates revealed increased
ubiquitination of PSD-95 in roscovitine-treated (R) slices relative to control (D), with a pattern of
discrete bands similar to that obtained in p35 knock-outmice. Quantification revealed that ubiquiti-
nation of PSD-95was 274.6 71.6%with roscovitine treatment versus 100 54.5% in untreated
control (n 4; p 0.01). Ubiquitin immunoreactivity was normalized to the level of immunopre-
cipitated PSD-95 and expressed as a percentage of DMSO control.C, PSD-95 is ubiquitinated onmul-
tiple lysines. PSD-95 immunoprecipitated from acute mouse forebrain slices treated with the Cdk5
inhibitor roscovitine (10M,45min)was subjected toLCMS/MSanalysis. Peptidesobtainedcovered
80%ofthePSD-95primaryaminoacidsequence(DLG4,mouse;Swiss-Protdatabase).Aschematic
view of PSD-95 domain structure with ubiquitinated lysines (K) is shown. Lysine residues ubiquiti-
nated are K 10 in theN terminus, K 403 in the linker between thePDZ3 and SH3domains, andK544,
K 672, andK679 in theGKdomain.
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(Src homology 3) domain, and a GK (guanylate kinase) domain
(Kim and Sheng, 2004; Montgomery et al., 2004). To identify the
ubiquitinated lysines on PSD-95, we performed high-resolution
tandem mass spectrometry analysis on PSD-95 immunoprecipi-
tated from acute mouse forebrain slices treated with roscovitine.
High molecular weight (MW) and long peptides generally pose
difficulty in collision-induced dissociation-type fragmentation
by most tandemmass spectrometers. Based on theoretically pre-
dicted digestion using various enzymes, we found that by includ-
ing either GluC (Staphylococcus aureus protease V8) or LysC
(endoproteinase from Lysobacter enzymogenes) with a trypsin di-
gestion of PSD-95, we eliminated all the highMWpeptides (pep-
tides with MW3500) generated from just using trypsin. The
combination of GluC or LysC with trypsin digestion resulted in
80% primary protein sequence coverage of PSD-95 (DLG4,
mouse; Swiss-Prot database), overlapping 29 of the 38 lysines,
with Lys 152, Lys 157, Lys 162, Lys 165, Lys 211, Lys 355, Lys 503,
Lys 505, and Lys 624, not represented. The presence of a Gly–
Gly moiety on a lysine residue corresponds to the C terminus
of the ubiquitin tag, which is present when trypsin (or a com-
bination of GluC/trypsin enzymes) is used for enzymatic di-
gestion before LC MS/MS analysis, and is indicative of
ubiquitination. We identified five lysine residues of PSD-95
that were ubiquitinated after roscovitine treatment (Fig. 1C):
Lys 10 in the N terminus, Lys 403 in the linker between PDZ3
and SH3 domains, and Lys 544, Lys 672, and Lys 679 in the GK
domain. These results indicate that, under decreased Cdk5
activity, the N terminus as well as the PDZ3/SH3 linker region
and the GK domain are ubiquitinated.
Mdm2 has been identified as the ubiquitin ligase for PSD-95
(Colledge et al., 2003). Since the ubiquitination of PSD-95 is
dependent onMdm2, the increase in PSD-95 ubiquitination that
we observed under reduced Cdk5 activity could reflect an in-
creased interaction of PSD-95 with Mdm2. To investigate
whether Cdk5 activity inversely correlates with the level of inter-
action of PSD-95 withMdm2, we analyzed PSD-95 immunopre-
cipitated from brain lysates of p35 knock-out mice and wild-type
littermates by immunoblotting with an Mdm2 antibody (Fig.
2A). Consistent with the increase in PSD-95 ubiquitination, the
interaction ofMdm2with PSD-95 increasedmore than threefold
in p35 knock-out mice compared to wild type (360.5 65.6% vs
100  20.6% for wild type; n  3; p  0.05). To further assess
whether Cdk5 regulates the level of PSD-95 association with
Mdm2,we analyzed roscovitine-treated cultured hippocampal neu-
rons by immunocytochemistry (Fig. 2B).We found that roscovitine
treatment increased the colocalization of Mdm2 with PSD-95
puncta compared toDMSO control sister cultures (149 27.4% vs
100  24.8% for control; n  4; p  0.05). Together these data
indicate that decreased Cdk5 activity increases colocalization and
interaction of Mdm2 with PSD-95, thus promoting PSD-95 ubiq-
uitination byMdm2.
Decreased Cdk5 activity increases PSD-95 ubiquitination
without a decrease in PSD-95 protein levels
Ubiquitination may occur by the addition of a single ubiquitin
moiety to one or multiple lysine residues (monoubiquitination)
or by addition of polymeric ubiquitin chains (polyubiquitina-
tion) (DiAntonio and Hicke, 2004; d’Azzo et al., 2005). While
Mdm2 can catalyze both monoubiquitination and polyubiquiti-
nation (Li et al., 2003), the discrete ubiquitinated PSD-95 species
that we observe and that were originally identified by Colledge et
al. (2003) suggest PSD-95 monoubiquitination onmultiple sites.
The FK1 and FK2monoclonal antibodies are used to differentiate
between monoubiquitination and polyubiquitination, since FK2
detects bothmonoubiquitinated and polyubiquitinated proteins,
while FK1 recognizes only polyubiquitinated proteins (Fujimuro
et al., 1994). Therefore, to assess whether the ubiquitination of
PSD-95 reflects monoubiquitination or polyubiquitination, we
tested PSD-95 from p35 knock-out mice for immunoblotting
with FK1 and FK2 antibodies. Immunoblotting of PSD-95 im-
munoprecipitated from p35 knock-out brain revealed that
PSD-95ubiquitination is detected by FK2, not FK1. Polyubiquiti-
nated species observed in the input lanes serve as a positive con-
trol for FK1 immunoreactivity (Fig. 3A). Similar results were
obtained with PSD-95 immunoprecipitated from roscovitine-
treated acute forebrain slices (Fig. 3B). The immunoreactivity of
PSD-95 to FK2 but not to FK1 suggests monoubiquitination of
PSD-95 onmultiple lysines and is consistent with the LCMS/MS
results.
While polyubiquitination has been mainly associated with
targeting of proteins for degradation by the 26S proteasome,
monoubiquitination has been implicated in nonproteasomal sig-
naling functions (Hicke and Dunn, 2003; DiAntonio and Hicke,
2004; d’Azzo et al., 2005; Chen and Sun 2009). To assess the
relationship between PSD-95 ubiquitination and degradation,
we analyzed the levels of PSD-95 in brain lysates of p35 knock-out
and wild-type mice (Fig. 3C) and in roscovitine-treated and con-
trol acute forebrain slices (Fig. 3D). We observed no significant
change in PSD-95 protein levels (normalized to actin) in p35
knock-out mice compared to wild-type littermates (120.7 
30.5% vs 100  15.7% for wild type; n  4; p  0.5) or in
roscovitine-treated slices compared to control (103.7 18.7% vs
100  15.8% for control; n  3; p  0.5). Thus, these results
indicate that PSD-95 ubiquitination does not directly correlate
with decreased PSD-95 protein levels, suggesting a nonproteo-
lytic function for ubiquitinated PSD-95 at the synapse.
Figure 2. Reduced Cdk5 activity increases interaction and colocalization ofMdm2with PSD-
95. A, p35 knock-out mice have increased interaction of Mdm2 with PSD-95. Immunoblots of
PSD-95 immunoprecipitated from brain lysates of wild-type (/) and p35 knock-out
(/) mice revealed increased interaction of PSD-95 with Mdm2 in p35 knock-out mice.
Quantification (mean SEM) revealed that coimmunoprecipitation ofMdm2with PSD-95was
360.5 65.6%versus 100 20.6% forwild type (n 3; p 0.05).Mdm2 immunoreactivity
was normalized to the level of immunoprecipitated PSD-95 and expressed as a percentage of
wild-type control. IgG, Control immunoprecipitationwithmouse IgG.B, Roscovitine treatment
increases the colocalization ofMdm2with PSD-95. Culturedhippocampal neuronswere treated
with the Cdk5 inhibitor roscovitine (10M, 45 min) or DMSO as a control and immunostained
forMdm2 and PSD-95. Representative confocal images from each condition are shown (Mdm2,
green; PSD-95, red). Scale bars: 10 m. Quantification revealed that in roscovitine-treated
cultures (R), the percentage of PSD-95 puncta positive for Mdm2 was 149 27.4% versus
100 24.8% the DMSO control (D) (n 4; p 0.05). The number of costained puncta, as a
percentage of total PSD-95 puncta, is expressed as a percentage of the number for DMSO
controls.
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PSD-95 ubiquitination promotes the interaction with the
clathrin endocytic adaptor complex AP-2
AMPAR endocytosis is mediated by the clathrin endocytic adap-
tor complex AP-2 (Carroll et al., 1999; Man et al., 2000). While
the function of PSD-95 in AMPAR endocytosis is not clear, it has
been shown that PSD-95 interacts with the AP-2 complex (Fer-
nandez et al., 2009), and the AP-2 binding motif (YXX	) within
the GK domain of PSD-95 (Y701HKV) is sufficient to mediate
clathrin-dependent endocytosis of the transmembrane protein
Tac (Craven and Bredt, 2000). Therefore, we hypothesize that
PSD-95 ubiquitination functions by regulating the interaction of
PSD-95 with the AP-2 complex.
Since p35 knock-out mice have increased PSD-95 ubiquitina-
tion, we used these mutant mice to assess whether PSD-95 ubiq-
uitination correlates with changes in PSD-95 interaction with
AP-2 in vivo.We analyzed the interaction of PSD-95with AP-2 in
brain lysates of p35 knock-out and wild-type littermates by im-
munoblotting immunoprecipitated PSD-95 for the AP-2 subunit
-adaptin (Fig. 4A). The interaction of PSD-95 with -adaptin
was significantly increased in p35 knock-outmice (265 55.8%)
versuswild type (100 16.4%;n 4; p 0.05).We also analyzed
whether -adaptin colocalizes with PSD-95 puncta in cultured
hippocampal neurons treated with roscovitine (Fig. 4B). Immu-
nocytochemistry analysis of these neurons revealed that roscovi-
tine treatment promotes colocalization of -adaptin with
PSD-95 puncta compared to DMSO-treated control sister neu-
rons (192.5 19% vs 100 15.6% for control; n 5; p 0.01).
Thus, these data indicate that decreased Cdk5 activity, which
promotes PSD-95 ubiquitination, also promotes the interaction
of PSD-95 with -adaptin. To further assess whether PSD-95
ubiquitination regulates the interaction with AP-2, we analyzed
PSD-95 immunoprecipitated from brain lysates of Mdm2/p53
double knock-outmice, sinceMdm2 knock-outmice die early in
development (Jones et al., 1995), and control p53 knock-out
mice (Fig. 4C). Immunoblot analysis of Mdm2/p53 double
knock-out brain lysates revealed decreased interaction of PSD-95
with-adaptin compared to control p53 knock-outmice (63.7
8.8% vs 100  10.8% for control; n  5; p  0.05). Together,
these results indicate a correlation between the genetic deletion of
Mdm2 and the decrease in PSD-95 interaction with -adaptin
and, conversely, between decreased Cdk5 activity and increased
PSD-95 interaction with -adaptin. Therefore, these results sup-
port a correlation between PSD-95 ubiquitination and interac-
tion with -adaptin, suggesting a function for ubiquitinated
PSD-95 in the regulation of its interaction with the AP-2/clathrin
endocytic complex.
PSD-95 ubiquitination is also induced by NMDA treatment
(Colledge et al., 2003); thus, we investigated whether NMDA
treatment regulates the interaction of PSD-95 with -adaptin.
Acute forebrain slices from adult wild-type mice were treated
with NMDA (100 M, 3 min), a treatment that induces AMPAR
endocytosis (Bhattacharyya et al., 2009), and analyzed at 5 and 10
min after NMDA washout. Immunoblot analysis of PSD-95 im-
munoprecipitated from the lysates revealed an increase in both
PSD-95 ubiquitination and interaction with -adaptin 10 min
after NMDAwashout (Fig. 4D). To further assess the correlation
between PSD-95 ubiquitination and interaction with -adaptin,
we analyzed acute brain slices of adult Mdm2/p53 double knock-
out mice and control p53 knock-out mice 5 and 10 min after
NMDA (100M, 3min)washout (Fig. 4E). Immunoblot analysis
of PSD-95 immunoprecipitated from lysates of control p53
knock-out mice revealed an increase in PSD-95 interaction with
-adaptin at 5 min (209.0 72.6%; n 3) and 10 min (549.8
168%; n 3) after washout compared to the unstimulated con-
trol condition (100 14.9%; n 3). In contrast, the interaction
of PSD-95 with -adaptin was consistently lower in Mdm2/p53
double knock-out slices in unstimulated conditions (50.5 
13.8%; n 3) at 5 min (45.6 1.8%; n 3) and 10 min (99.8
43.7%; n 3) after NMDA washout compared to unstimulated
p53 knock-out control conditions. All the values obtained for the
PSD-95/-adaptin interaction in p53 and Mdm2/p53 double
knock-outs were statistically significant (p  0.005, ANOVA).
These results indicate that the interaction of PSD-95 with
-adaptin is regulated by NMDARs and depends on Mdm2 ex-
pression. Thus, together these data support a direct correlation
Figure 3. Ubiquitination of PSD-95 does not alter PSD-95 protein levels. A, PSD-95 is
monoubiquitinated on multiple lysines in p35 knock-out mice. PSD-95 immunoprecipitated
from brain lysates of wild-type (/) and p35 knock-out (/) mice immunoblotted with
the FK2 antibody, which recognizes polyubiquitinated and monoubiquitinated proteins. FK2
immunoblot analysis revealed increasedPSD-95ubiquitination in p35 knock-outmice,with the
samepattern of discrete bands observedwith the ubiquitin antibody. Immunoblotwith the FK1
antibody, which recognizes only polyubiquitinated proteins, did not reveal immunoreactive
bands (right). Immunoblotting of polyubiquitinated proteins in the input serves as a positive
control for FK1. B, Roscovitine treatment increases PSD-95 monoubiquitination on multiple
lysines. Acutemouse forebrain sliceswere treatedwith theCdk5 inhibitor roscovitine (R; 10M,
45 min) or DMSO (D) as a control. Immunoblots of PSD-95 immunoprecipitated from lysates of
the treated slices revealed FK2 immunoreactivitywith a pattern of discrete bands similar to that
obtained in p35 knock-out mice. FK1 immunoblots did not reveal immunoreactive bands from
immunoprecipitated PSD-95 as for the p35 knock-out mice (right). Immunoblotting of polyu-
biquitinated proteins in the input serves as a positive control for FK1. C, PSD-95 ubiquitination
does not alter PSD-95 protein levels. Brain lysates from wild-type (/) and p35 knock-out
(/) mice were immunoblotted for PSD-95 and actin. Quantification (mean SEM) re-
vealed that PSD-95protein levels in thep35knock-outmicewere120.730.5%versus 100
15.7% for wild type (n 4; p 0.5). PSD-95 immunoreactivity was normalized to actin and
expressed as a percentage of wild-type control mice. D, Roscovitine treatment does not affect
the protein levels of PSD-95. Brain lysates from acute mouse forebrain slices treated with the
Cdk5 inhibitor roscovitine (10M, 45min) or DMSO as control were immunoblotted for PSD-95
and actin. Quantification revealed that PSD-95 protein levels in the roscovitine samples were
103.7 18.7% versus 100 15.8% for DMSO controls (n 3; p 0.5). PSD-95 immunore-
activity was normalized to actin and expressed as a percentage of DMSO control levels.
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between PSD-95 ubiquitination and interaction with AP-2, sug-
gesting that PSD-95 ubiquitination may function in NMDAR-
dependent AMPAR endocytosis by regulating the interaction
with the clathrin endocytic adaptor complex AP-2.
Discussion
Cdk5has been implicated in synaptic plasticity, but themolecular
mechanisms are still not clear. PSD-95 ubiquitination by Mdm2
is stimulated by NMDAR activity and has been implicated in the
regulation of NMDAR-induced internalization of AMPARs dur-
ing synaptic plasticity. Here we show that PSD-95 ubiquitination
is increased by genetic or pharmacological
reduction of Cdk5 activity reflects ubiq-
uitination on multiple lysines and does
not correlate with decreased PSD-95 pro-
tein levels in vivo. We also show that
PSD-95 ubiquitination correlates with in-
creased interaction with the AP-2 com-
plex both in p35 knock-out mice, which
have reduced Cdk5 activity, and by direct
stimulation of acute forebrain slices with
NMDA. Together these results suggest a
molecularmechanism bywhich Cdk5 im-
pacts synaptic plasticity by regulating
PSD-95 ubiquitination and its interaction
with AP-2.
We provide evidence that reduced Cdk5
activity promotes the colocalization and in-
teraction of Mdm2 with PSD-95 and the
ubiquitination of PSD-95 in neurons.
Mdm2 activity is regulated by numerous
signaling pathways and is affected by
changes in its stability and intracellular dis-
tribution (Mukhopadhyay and Riezman,
2007; Wade et al., 2010). Thus, reduced
Cdk5 activity may promote PSD-95 ubiq-
uitinationbyregulating the intracellulardis-
tributionofMdm2withinneurons,possibly
by increasing Mdm2 levels at the PSD.
Mdm2 can catalyze both monoubiquitina-
tion and polyubiquitination of the tumor
suppressor p53 (Li et al., 2003) and the pat-
tern of discrete bands of ubiquitinated
PSD-95 observed by Colledge et al., (2003),
and in our experiments, suggests monou-
biquitination on multiple lysines. Our
study, using the differential immunoreac-
tivity to the FK1 and FK2 antibodies, is con-
sistent with PSD-95 monoubiquitination
onmultiple lysines.We have also identified,
by high-resolution mass spectrometry, five
ubiquitinated residues in PSD-95 from
roscovitine-treated samples, although some
regions of PSD-95 were not covered by our
analysis, possibly due to ions not being ion-
ized in the positive mode in the mass spec-
trometer, therefore making the peptides
more observable in the negativemode (Toll
et al., 2005). The identification of five ubi-
quitinated lysine residues in PSD-95 sug-
gests that the three distinct bands of
ubiquitinated PSD-95 observed in our ex-
periments and by Colledge et al., (2003)
may represent different combinations of
ubiquitinated residues, with the high molecular weight band being
consistentwith threeubiquitinated residues. Interestingly, oneof the
lysines (Lys 10) is within the N-terminal domain of PSD-95, which
has been implicated in homotypic interactions (Hsueh et al., 1997;
Morabito et al., 2004;Xuet al., 2008). Lysine10 is also adjacent to the
PEST [proline (P), glutamic acid (E), serine (S), and threonine (T)
rich]motif of PSD-95,which is required forNMDAR-inducedAM-
PAR endocytosis (Colledge et al., 2003). Additional ubiquitinated
lysines are in the linker between the PDZ3 and SH3 domains (Lys
403) andwithin theGKdomain (Lys 544, Lys 672, andLys 679). The
Figure 4. PSD-95 ubiquitination correlates with PSD-95 interaction with AP-2. A, p35 knock-out mice have increased PSD-95
interaction with-adaptin, a subunit of the clathrin endocytic adaptor complex AP-2. Immunoblots of PSD-95 immunoprecipi-
tated from brain lysates of p35 knock-out (/) and wild-type (/) mice revealed increased interaction of PSD-95 with
-adaptin in p35 knock-outs. Quantification (mean SEM) revealed that the coimmunoprecipitation of-adaptin with PSD-95
was 265 55.8% of 100 16.4% for wild type (n 4; p 0.05).-Adaptin immunoreactivity was normalized to the level of
immunoprecipitated PSD-95 and expressed as a percentage of wild-type control. IgG, Control immunoprecipitation with mouse
IgG. B, Pharmacological inhibition of Cdk5 increases the colocalization of PSD-95 with-adaptin. Cultured hippocampal neurons
treatedwith the specific Cdk5 inhibitor roscovitine (10M, 45min) or DMSOas a controlwere immunostainedwith-adaptin and
PSD-95 antibodies. Representative confocal images fromeach condition are shown (-adaptin, green; PSD-95, red). Scale bars: 10
m. Quantification revealed that in roscovitine-treated cultures (R) recruiting the clathrin/AP-2 endocytic complex, the percent-
age of PSD-95 puncta positive for-adaptin was 192.5 19% of 100 15.6% for the DMSO control (D; n 5; p 0.01). The
number of costainedpuncta, as a percentageof total PSD-95puncta, is expressed as apercentageof thenumber for DMSO controls.
C,Mdm2nullmice have decreased interaction of PSD-95with-adaptin. Immunoblots of PSD-95 immunoprecipitated frombrain
lysates of p53/Mdm2double knock-out (/) andp53 knock-out controlmice (/) revealed decreased interaction of PSD-95
with -adaptin in p53/Mdm2 double knock-out mice. Quantification revealed that coimmunoprecipitation of -adaptin with
PSD-95 was 63.7 8.8% of 100 10.8% for the p53 knock-out control (n 5; p 0.05).-Adaptin immunoreactivity was
normalized to the level of immunoprecipitated PSD-95 and expressed as a percentage of p53 knock-out control levels. D, NMDA
receptors regulate PSD-95 ubiquitination and interaction with-adaptin. Acute forebrain slices from wild-type mice were stim-
ulated with NMDA (100M, 3 min) and, after NMDA washout, incubated for an additional 5 or 10 min. Immunoblots of PSD-95
immunoprecipitated from lysates revealed increased coimmunoprecipitation of-adaptinwith PSD-95 10min after NMDAwash-
out (10) compared to the unstimulated control (C). FK2 immunoblots of PSD-95 revealed increased PSD-95 ubiquitination 10min
after NMDAwashout (10) compared to the unstimulated control (C). E, Mdm2 null mice have reduced NMDA-dependent interac-
tion of PSD-95with-adaptin. Acute forebrain slices from control p53 knock-out (/) andMdm2/p53 double knock-outmice
(/) were stimulated with NMDA (100 M, 3 min) and, after NMDA washout, incubated for an additional 5 or 10 min.
Quantification of immunoblots of PSD-95 immunoprecipitated from p53 knock-out lysates revealed increased coimmunoprecipi-
tation of-adaptinwith PSD-95 5min after the end of NMDA treatment (209.0 72.6%; n 3), and a further increase at 10min
(549.8 167.7%; n 3) compared to the unstimulated control (100 14.9%; n 3). In contrast, compared to the unstimu-
lated p53 knock-out control, the levels of coimmunoprecipitation of -adaptin with PSD-95 were lower in Mdm2/p53 double
knock-out mice at all times points in unstimulated slices (50.5 13.8%; n 3) as well as at 5 and 10min after the end of NMDA
treatment (45.6 1.8% and 99.8 43.7%, respectively; n 3; p 0.005, ANOVA).-Adaptin immunoreactivity was normal-
ized to the level of immunoprecipitated PSD-95 and expressed as a percentage of p53 knock-out unstimulated controls.
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SH3 andGKdomains are linked by a pair of antiparallel strands and
forman integrated structural unit (McGee et al., 2001; Tavares et al.,
2001). Lys 544, Lys 672, and Lys 679 are within  helix structures of
theGKdomain, suggesting thatubiquitinationof these residuesmay
change the conformation of the SH3/GK domain through the steri-
cal presence of the ubiquitin moiety, making PSD-95 more accessi-
ble for protein interactions. In addition, the SH3 and GK domains
are important for the localization of PSD-95 at the PSD, and hence
for the effect of PSD-95 on AMPAR EPSCs (Xu et al., 2008). Thus,
addition of ubiquitin moieties to these domains may regulate
PSD-95protein interactions, theorganizationof signalingmolecules
and cytoskeletal elements, and the strengthof synaptic transmission.
In our study, PSD-95 ubiquitination does not correlate with
its degradation both in p35 knock-out brain in vivo and in
roscovitine-treated neurons, and is consistent with PSD-95
monoubiquitination. Previous studies have associated PSD-95
ubiquitination with its proteasomal degradation by showing that
deletion of the PEST motif in PSD-95 or treatment with the pro-
teasome inhibitor MG132 (C26H41N3O5) protects PSD-95 from
degradation (Colledge et al., 2003). Interestingly, the proteases
calpain and caspase can catalyze PSD-95 degradation (Lu et al.,
2000; Vinade et al., 2001; Gasco´n et al., 2008; Liu et al., 2010), and
MG132 is also an inhibitor of calpains (Lee and Goldberg, 1998;
Elliott et al., 2003). Furthermore, Lys 10 in PSD-95, which is
ubiquitinated under reduced Cdk5 activity, is adjacent to the
PESTmotif, which has been implicated in proteolysis by caspases
(Belizario et al., 2008) and calpains (Rechsteiner and Rogers,
1996; Shumway et al., 1999).
Our studies suggest a novel function for ubiquitinatedPSD-95
at the synapse in the regulation of PSD-95 interaction with the
clathrin endocytic adaptor complex AP-2. We observe a correla-
tion between reduction of Cdk5 activity, increased PSD-95 ubiq-
uitination, and increased PSD-95 interaction with -adaptin, a
component of AP-2/clathrin adaptor protein complex. We also
observe the NMDAR-dependent increase in PSD-95 ubiquitina-
tion, first described by Colledge et al., (2003), accompanied by
the increase in PSD-95 interaction with -adaptin. The correla-
tion between PSD-95 ubiquitination and increased interaction
with AP-2 is further supported by our observation that, whereas
in p53 knock-out mice NMDAR activity induces an increase in
PSD-95 interaction with -adaptin, this increase is greatly re-
duced in mice with a genetic deletion of Mdm2. Our results are
consistent with previous studies indicating an interaction be-
tween PSD-95 and AP-2 (Fernandez et al., 2009) and a function
for the motif within the GK domain of PSD-95 in mediating the
clathrin-dependent endocytosis of the transmembrane protein
Tac (Craven and Bredt, 2000). Together these observations sug-
gest that ubiquitinated PSD-95 functions in recruiting the
clathrin/AP-2 endocytic complex and possibly regulating the in-
teractionwith other postsynaptic proteins.Our data demonstrate
that Cdk5 regulates the ubiquitination of PSD-95 and its interaction
withAP-2.Given that ubiquitinationofPSD-95has been implicated
in NMDAR-induced endocytosis of AMPARs, the recruitment of
the clathrin/AP-2 endocytic complex by PSD-95 could provide a
mechanismbywhichCdk5 couldmodulateAMPAR internalization
during synaptic plasticity.
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